4-bromo-2-fluoro-1-methoxybenzene | CAS:2357-52-0

We serve 4-bromo-2-fluoro-1-methoxybenzene CAS:2357-52-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-bromo-2-fluoro-1-methoxybenzene

Chemical Name: 4-bromo-2-fluoro-1-methoxybenzene
CAS.NO: 2357-52-0
Synonyms: 3-fluoro-4-methoxybromobenzene;
Benzene,4-bromo-2-fluoro-1-methoxy;
4-Bromo-2-fluoroanisole;
3,4-Difluorobenzoic acid;
2-fluoro-4-bromo anisole;
Molecular Formula:C7H6BrFO
Molecular Weight: 205.02400
 
Physical and Chemical Properties:
Density: 1.59 g/mL at 25 °C(lit.)
Melting point: 16 °C
Boiling point: 84 °C7 mm Hg(lit.)
Flash point:  209 °F
Index of Refraction:1.545
 
Specification:
Appearance: colorless liquid
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:   Applications for organic intermediates



Contact us for information like 4-bromo-2-fluoro-1-methoxybenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-fluoro-4-bromo anisole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-bromo-2-fluoro-1-methoxybenzene Use and application,Benzene,4-bromo-2-fluoro-1-methoxy technical grade,usp/ep/jp grade.


Related News: Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.(R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one manufacturer Delta said it will suspend flights between the United States and China starting on Sunday until at least April 30, according to a press release.3-Hydroxy-2'-methyl-2-naphthanilide supplier The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).2-((4-(Carboxymethyl)phenoxy)methyl)benzoic acid vendor Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.